Clinical Trial Update: Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy of NNC0142-0002 in rheumatoid arthritis has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• NNC0142-0002

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Inflammation, Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-04-28